Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Overview of attention for article published in mBio, March 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 6,620)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 48 news outlets
blogs: 2 blogs
twitter: 358 X users
patent: 7 patents

facebook: 3 Facebook pages
wikipedia: 17 Wikipedia pages
video: 2 YouTube creators

Citations

dimensions_citation: 1195 Dimensions

Readers on

mendeley: 1653 Mendeley

Summary News Blogs X Patents Facebook Wikipedia YouTube Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

Warum Remdesivir (noch) nichts bringt

AstroGeo, 04 May 2020

Remdesivir ist das erste Medikament gegen Covid-19. Das ist gut. Unglücklicherweise bringt es uns im Moment noch nichts.

First Evidence that the Antiviral Remdesivir Shows Efficacy in an Animal Model (Rhesus Macaques) of COVID-19

BrainImmune: Trends in Neuroendocrine Immunology, 24 Apr 2020

As reported by Brandi Williamson et al. in bioRxiv, remdesivir is the first antiviral treatment with proven efficacy against…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.